FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

39362811000001101: Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2284591000001117 Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2284601000001114 Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has dispensed dose form Conventional release dispersion for infusion true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Is a Brexucabtagene autoleucel true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has specific active ingredient Brexucabtagene autoleucel true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has specific active ingredient Brexucabtagene autoleucel false Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Is a Brexucabtagene autoleucel false Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has dispensed dose form Dispersion for infusion false Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route dispersioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags 1 bag Has VMP True Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Inferred relationship Existential restriction modifier
Tecartus 40million-200million cells/68ml dispersion for infusion bags (Gilead Sciences Ltd) Is a True Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start